Communiqués

12/04/23 Neovasc : Notice of Change in Corporate Structure - Form 6-K PU
03/04/23 Neovasc Announces Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Corporate Update AQ
31/03/23 Neovasc: Q4 Earnings Snapshot AQ
31/03/23 Neovasc Announces Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Corporate Update GL
06/03/23 Neovasc : Shareholders Approve Acquisition by Shockwave Medical PU
01/02/23 Neovasc Announces German Reimbursement Renewal AQ
27/01/23 Neovasc : Notice of the Meeting and Record Date - Form 6-K PU
17/01/23 IIROC Trade Resumption - NVCN AQ
17/01/23 IIROC Trading Halt - NVCN AQ
17/01/23 Shockwave Medical Announces Agreement to Acquire Neovasc AQ
17/01/23 Shockwave Medical to Acquire Neovasc AQ
28/11/22 Neovasc Announces Progress on COSIRA-II Clinical Trial AQ
18/11/22 Neovasc Comments on European Heart Journal Publication AQ
11/11/22 Neovasc: Q3 Earnings Snapshot AQ
10/11/22 Neovasc Announces Third Quarter Financial Results and Provides Corporate Update AQ
08/11/22 Neovasc Reducer Obtains U.S. Outpatient Reimbursement AQ
27/10/22 Neovasc to Report Third Quarter Financial Results on November 10, 2022 AQ
20/09/22 Neovasc : New Data Presented on the Neovasc Reducer™ in Patients With Microvascular Disease - Form 6-K PU
20/09/22 Neovasc Provides Corporate Update Following Clinical Data Release AQ
16/09/22 Neovasc to Participate in LSI Europe 2022 Emerging MedTech Summit AQ
15/09/22 Neovasc Comments on New ICD-10-CM Diagnosis Codes for Refractory Angina AQ
08/09/22 Neovasc Announces Key Events at TCT 2022 AQ
30/08/22 Neovasc to Participate in H.C. Wainwright 24th Annual Global Investment Conference AQ
11/08/22 Neovasc: Q2 Earnings Snapshot AQ
11/08/22 Neovasc : Announces Second Quarter Financial Results and Provides Corporate Update - Form 6-K PU
Aucun résultat pour cette recherche